company background image
0YX logo

Sysmex DB:0YX Stock Report

Last Price

€17.40

Market Cap

€11.1b

7D

-2.2%

1Y

2.4%

Updated

22 Dec, 2024

Data

Company Financials +

0YX Stock Overview

Engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. More details

0YX fundamental analysis
Snowflake Score
Valuation0/6
Future Growth2/6
Past Performance5/6
Financial Health5/6
Dividends4/6

My Notes

Capture your thoughts, links and company narrative

Sysmex Corporation Competitors

Price History & Performance

Summary of share price highs, lows and changes for Sysmex
Historical stock prices
Current Share PriceJP¥17.40
52 Week HighJP¥20.40
52 Week LowJP¥13.60
Beta0.63
1 Month Change-8.42%
3 Month Change1.75%
1 Year Change2.35%
3 Year Change-55.38%
5 Year Change-14.43%
Change since IPO55.79%

Recent News & Updates

Recent updates

Shareholder Returns

0YXDE Medical EquipmentDE Market
7D-2.2%-2.9%-2.6%
1Y2.4%-8.5%6.9%

Return vs Industry: 0YX exceeded the German Medical Equipment industry which returned -8.5% over the past year.

Return vs Market: 0YX underperformed the German Market which returned 6.9% over the past year.

Price Volatility

Is 0YX's price volatile compared to industry and market?
0YX volatility
0YX Average Weekly Movement7.1%
Medical Equipment Industry Average Movement6.6%
Market Average Movement4.8%
10% most volatile stocks in DE Market11.2%
10% least volatile stocks in DE Market2.4%

Stable Share Price: 0YX's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: 0YX's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of German stocks.

About the Company

FoundedEmployeesCEOWebsite
196810,042n/awww.sysmex.co.jp

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.

Sysmex Corporation Fundamentals Summary

How do Sysmex's earnings and revenue compare to its market cap?
0YX fundamental statistics
Market cap€11.14b
Earnings (TTM)€327.65m
Revenue (TTM)€3.01b

34.0x

P/E Ratio

3.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
0YX income statement (TTM)
RevenueJP¥491.29b
Cost of RevenueJP¥228.51b
Gross ProfitJP¥262.78b
Other ExpensesJP¥209.32b
EarningsJP¥53.46b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Feb 12, 2025

Earnings per share (EPS)85.73
Gross Margin53.49%
Net Profit Margin10.88%
Debt/Equity Ratio7.1%

How did 0YX perform over the long term?

See historical performance and comparison

Dividends

1.0%

Current Dividend Yield

34%

Payout Ratio

Does 0YX pay a reliable dividends?

See 0YX dividend history and benchmarks
When do you need to buy 0YX by to receive an upcoming dividend?
Sysmex dividend dates
Ex Dividend DateMar 28 2025
Dividend Pay DateJun 24 2025
Days until Ex dividend95 days
Days until Dividend pay date183 days

Does 0YX pay a reliable dividends?

See 0YX dividend history and benchmarks

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 01:30
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Sysmex Corporation is covered by 35 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yoshitsugu SasakiAizawa Securities Co. Ltd.
Masahiro NakanomyoBarclays
Craig NelsonBNP Paribas Securities (Asia)